Subscribe to RSS Feed
Progress in science, medicine and health. EMA publishes 2015 annual report
The European Medicines Agency’s (EMA) 2015 annual report published today focuses on the Agency’s core tasks which include the evaluation of medicines,...
New treatment for rare white blood cell cancer
Treatment of follicular lymphoma to be added to Gazyvaro’s approved uses
New treatment for patients with multiple myeloma
Darzalex recommended for conditional approval
ECCO'16 Press Conference: ECCO-EFCCA Patient Guidelines
Press conference at the 11th Congress of ECCO – Inflammatory Bowel Diseases (Amsterdam, March 16, 2016)
Sneaking through barrier gaps: Gut microbiota imbalance harms the liverSneaking through barrier gaps: Gut microbiota imbalance harms the liver
(March 14, 2016) The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions only. Prominent among the other organs that might...
Launch of PRIME – Paving the way for promising medicines for patients
New scheme supports European Commission priorities
Queen’s chemists devise new approach for rapidly identifying ‘legal highs’
Chemists from Queen’s University Belfast have developed a new approach which now allows for rapid screening and identification of ‘legal highs’ or novel...
Cardiorentis’ Ularitide could make waves in Acute Decompensated Heart Failure market, says GlobalData Analyst
• Ularitide, a recently fast-tracked drug in development for acute decompensated heart failure, has the potential to bring valuable new therapeutic options to...
New ADHD Drug Adzenys Addresses Unmet Need for Patients who Struggle to Swallow Tablets, says GlobalData Analyst
• Neos Therapeutics’ new ADHD drug, Adzenys, is set to address problems associated with patients who struggle to swallow tablets
Queen’s University in bid to increase European cancer survival to 70% by 2035
To mark World Cancer Day, scientists at Queen’s University Belfast are launching a Europe-wide initiative, ‘Vision 70:35’, to increase cancer survival to...
EMA advice on use of colistin in animals to be updated
EMA acts upon request from European Commission following detection of colistin-resistant bacteria
Shaping the future of human and animal health in the EU
EMA Management Board and Heads of Medicines Agencies adopt network strategy to 2020
EMA ready to address challenges ahead
Support to innovative medicines, transparency and patient involvement will be among the priorities of new EMA Executive Director Guido Rasi
FIND announces innovative partnership with Janssen to accelerate access to TB diagnosis, treatment & care
3 Dec. 2015 – Cape Town, South Africa – FIND is pleased to announce an innovative collaborative agreement with Janssen Pharmaceutica NV (Janssen) to...
FIND AND CEPHEID announce a strategic collaboration to advance point-of-care TB diagnosis
CAPE TOWN, SOUTH AFRICA; GENEVA, SWITZERLAND; SUNNYVALE, CALIFORNIA – December 3, 2015 – FIND and Cepheid (Nasdaq: CPHD) today announced that they are...
European Antibiotic Awareness Day 2015: EMA reinforces commitment to help combat antimicrobial resistance
Speed up development of new treatments, promote responsible use of antimicrobials and collect data to advise policy and research - the European Medicines Agency...